# Extended Use of ModraDoc006/r

> **NCT03150368** · PHASE1 · COMPLETED · sponsor: **Modra Pharmaceuticals** · enrollment: 17 (actual)

## Conditions studied

- Advanced Solid Tumours

## Interventions

- **DRUG:** ModraDoc006/r

## Key facts

- **NCT ID:** NCT03150368
- **Lead sponsor:** Modra Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-05-10
- **Primary completion:** 2018-05-16
- **Final completion:** 2019-05-16
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2021-10-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03150368

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03150368, "Extended Use of ModraDoc006/r". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03150368. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*